查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1461236

癌症資訊系統市場評估：依產品和服務、應用、最終用戶和地區劃分的機會和預測（2017-2031）

Oncology Information System Market Assessment, By Product and Service, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 220 Pages | 商品交期: 3-5個工作天內

價格

全球癌症資訊系統市場規模將從2023年的32.3億美元成長到2031年的57億美元，在2024年至2031年的預測期內複合年增長率為7.35%。

癌症資訊系統 (OIS) 市場的成長主要是由全球癌症患者數量不斷增加所推動的。 對 OIS 簡化患者資訊和資料管理的需求不斷增長，促使不同類型的 OIS 軟體激增。 此外，公司增加對癌症研究的投資預計將推動市場擴張。 根據世界衛生組織 (WHO) 到 2030 年消除子宮頸癌這個公共衛生問題的目標，各國政府正在增加癌症研發的資金。 此類舉措不僅提高了意識，也推動了市場成長。

癌症病人增加：

由於癌症仍然是全球死亡的重要原因，技術和軟體系統的整合在癌症治療中發揮重要作用。 由於生活方式的改變，癌症發生率不斷上升，尤其是在老年人中，這是對癌症治療資訊系統需求的主要驅動力。 預計到 2022 年，將有 2,000 萬人被診斷出罹患癌症，970 萬人將死亡，約 5,350 萬人將在診斷後五年內生存。 統計數據顯示，五分之一的人一生中將面臨癌症診斷，九分之一的男性和十二分之一的女性將受到這種疾病的影響。 人們正在採用電子健康記錄（EHR）系統來支援醫療保健專業人員的循證決策並簡化患者護理協調。 癌症資訊系統管理電子病歷，改善以病人為中心的服務，瞭解疾病的病因，實現疾病的早期發現，並促進獲得更有效的治療。 為了確保患者在治療期間接受準確的輻射劑量，對準確、高效的輻射檢測系統的需求至關重要。 癌症治療的進展正在朝著精準醫學和客製化治療計畫的方向發展，凸顯了利用資訊系統有效利用先進技術診斷結果的重要性。 這些系統儲存、處理和共享文檔，從而可以對診斷進行徹底分析並制定適當的治療策略。 根據美國癌症協會雜誌2022年1月發表的一篇文章，美國報告的癌症病例數已增加至約190萬例。

醫療保健 IT 的快速成長

醫療保健IT市場與醫療技術、醫療保健、醫療器材、數位健康等各個領域交叉，現代科技進步正在重塑傳統的醫療保健服務和研究系統。 整合的醫療保健 IT 生態系統可解決癌症照護連續性方面的差距，同時簡化流程並降低效率。 最大限度地減少醫療冗餘，使醫院系統能夠跨提供者無縫提供以患者為中心的護理。 透過採用各種醫療保健 IT 解決方案，包括 EMR、RIS、PACS、VNA 和治療計劃解決方案，醫療保健組織可以提高護理質量，同時降低營運費用並滿足關鍵最終用戶群的需求。

與傳統的本地解決方案相比，基於雲端的解決方案具有眾多優勢，包括更高的可訪問性、可擴展性和成本效益。 基於雲端的解決方案促進與 EHR 系統和其他醫療保健 IT 平台的無縫集成，促進不同醫療保健環境之間的患者資料共享和協作。 人工智慧和機器學習演算法簡化了複雜醫學影像數據的分析和解釋，提高了癌症診斷和治療計劃的準確性和效率。

本報告調查了全球癌症資訊系統市場，提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及影響市場成長的因素。等等。

目錄

第一章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第四章癌症資訊系統市場展望

  • 市場規模/預測
  • 依產品/服務
    • 病患資訊系統
    • 治療計畫系統
    • 治療管理/醫學影像分析系統
    • 諮詢與優化服務
    • 實施服務
    • 售後服務/維修服務
  • 依用途
    • 腫瘤學
    • 放射腫瘤
    • 腫瘤外科
  • 依最終用戶
    • 醫院
    • 癌症護理中心
    • 政府機構
    • 研究設施
    • 其他
  • 依地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東/非洲
  • 各公司的市佔率

第 5 章癌症資訊系統市場展望：依地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第 6 章市場映射

  • 依產品和服務
  • 依用途
  • 依最終用戶
  • 依地區

第七章宏觀環境與產業結構

  • 需求與供給分析
  • 匯入/匯出分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

  • 生長促進因素
  • 抑製成長的因素（問題/障礙）

第 9 章監理架構與創新

  • 專利情況
  • 創新/新興技術

第十章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家參與公司）

第 11 章案例研究

第十二章主要公司展望

  • Siemens Healthineers
  • F. Hoffmann-La Roche AG
  • McKesson Corporation
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies, Inc.
  • Elekta Medical Systems India Pvt. Ltd.
  • IBM Watson Health
  • Oracle Cerner
  • Epic Systems Corporation
  • RaySearch Laboratories AB

第 13 章策略建議

第十四章查詢/免責聲明

Product Code: MX11236

Global oncology information system market is projected to witness a CAGR of 7.35% during the forecast period 2024-2031, growing from USD 3.23 billion in 2023 to USD 5.7 billion in 2031. The growth of the oncology information system (OIS) market is primarily fueled by the increasing prevalence of cancer cases worldwide. There's a rising demand for OIS to streamline patient information and data management, leading to a surge in various types of OIS software. Additionally, increasing investments in cancer research by companies are anticipated to propel market expansion. Governments are increasing their funding for oncology research and development, aligning with the World Health Organization's goal of eliminating cervical cancer as a public health concern by 2030. Such initiatives not only raise awareness but also drive market growth.

In August 2022, the Koita Centre for Digital Oncology (KCDO) was established by the National Cancer Grid (NCG) to promote digital technology and tools for enhancing cancer care across India. The Koita Foundation provided funding for the center's establishment, with commitments for continued support over the next five years. An MoU was signed between the Tata Memorial Centre and Koita Foundation at the Tata Memorial Hospital in Mumbai. These initiatives were expected to contribute to market growth and enhance cancer care in India. The KCDO aims to serve as a platform for collaboration and knowledge exchange among oncology healthcare professionals, researchers, and innovators. Moreover, the center plans to develop and implement digital solutions to enhance cancer screening, diagnosis, and treatment outcomes.

Rising Occurrence of Cancer Cases

The integration of technology and software systems plays a vital role in cancer treatment, given that cancer remains a significant global cause of mortality. The increasing prevalence of cancer, particularly among the elderly due to lifestyle changes, is a key driver for the demand for oncology information systems. Projections for 2022 anticipated 20 million new cancer cases and 9.7 million deaths from the disease, with approximately 53.5 million survivors within five years of diagnosis. Statistics show that one in five individuals will face a cancer diagnosis during their lifetime, with one in nine men and one in twelve women succumbing to the disease. Electronic health record (EHR) systems are being adopted to support evidence-based decision-making among healthcare professionals and streamline patient care coordination. Oncology information systems manage EHRs, improving patient-centric services, understanding disease etiology, enabling early disease detection, and facilitating access to more effective treatment modalities. The demand for precise and efficient radiation detection systems is critical for ensuring patients receive accurate radiation dosages during treatment. Advancements in cancer care are moving towards precision medicine and tailored treatment plans, emphasizing the importance of leveraging information systems to utilize diagnostic results from advanced technologies effectively. These systems store, process, and share documentation, enabling thorough analysis of diagnoses and the formulation of appropriate treatment strategies. As per an article published in January 2022, by the American Cancer Society Journal, the number of cancer cases reported has increased to approximately 1.9 million in the United States.

Rapid Growth in Healthcare IT

The healthcare IT market intersects with various sectors, including medical technology, healthcare, medical devices, and digital health, reshaping traditional healthcare delivery and research systems through modern technological advancements. An integrated healthcare IT ecosystem addresses gaps in oncology care continuity while streamlining processes and reducing inefficiencies. It minimizes healthcare redundancies, enabling hospital systems to deliver patient-centric care seamlessly across healthcare providers. Consequently, adopting different healthcare IT solutions, such as EMR, RIS, PACS, VNA, and treatment planning solutions, has led healthcare organizations to decrease operational expenses while enhancing the quality of care, driving market demand among major end-user segments.

The market is propelled by the increasing adoption of cloud-based solutions, which offer numerous advantages over traditional on-premises alternatives, including enhanced accessibility, scalability, and cost-effectiveness. Cloud-based solutions facilitate seamless integration with EHR systems and other healthcare IT platforms, facilitating the sharing and collaboration of patient data across various healthcare settings. AI and ML algorithms streamline the analysis and interpretation of intricate medical imaging data, enhancing cancer diagnosis and treatment planning accuracy and efficiency.

In February 2023, New Jersey Cancer Care announced the commencement of remote patient monitoring services to drive innovation in oncology. The cancer care center integrates medical devices with patient apps through this initiative, fostering a more connected and proactive approach to patient care.

Dominance of Radiation Oncology

Through the projected period, radiation oncology is expected to experience significant growth at an impressive CAGR. Radiation therapy constitutes a vital aspect of cancer treatment, given the global prominence of cancer as a leading cause of mortality. With the increasing adoption of radiosurgery, the demand for radiation oncology has surged, leading radiological departments to generate extensive data on cancer cases. Effective radiation therapy necessitates treatment planning and simulation to precisely administer radiation doses to target tumors while minimizing harm to surrounding healthy tissues. Oncology information systems offer specialized tools and modules tailored for radiation treatment planning, encompassing dose calculations, treatment simulations, contouring, and image fusion. These systems empower radiation oncologists to devise optimal treatment strategies and simulate the delivery process, ensuring precision and safety. Furthermore, the growing global demand for radiation therapies in cancer treatment catalyzes the segment's expansion. The imperative for precise and efficient radiation detection systems arises to ensure patients receive the correct radiation dosage during treatment. Diagnostic imaging techniques employing ionizing radiation, such as CT scans, PET scans, and X-rays, play a crucial role in cancer diagnosis. Increased government investment in healthcare, as evidenced by data from the National Institutes of Health indicating a rise in US healthcare expenditure for biomedical imaging from USD 2.7 billion in 2022 to USD 3.1 billion in 2023, is also driving the demand for oncology information systems. In February 2024, Kormek Group was awarded £1.3 million (USD 1.6 million) to participate in the Intelligent Radiation Sensor Readout System (i-RASE) project for developing a new class of radiation sensors powered by artificial intelligence (AI).

North America Is Dominating the Global Oncology Information System Market

North America is poised to dominate the oncology information system market throughout the projected timeframe. This can be attributed to factors like the increasing incidence of cancer and the presence of advanced healthcare infrastructure. According to the cancer facts and figures report for 2023 from the American Cancer Society, approximately 1.9 million new cancer cases are expected to be diagnosed in 2023. Notably, prostate cancer is projected to lead with an estimated 288,300 cases, followed by lung cancer with 238,340 cases, and female breast cancer with 300,590 cases. Similarly, data released by the Government of Canada in May 2022 revealed that around 233,900 Canadians received cancer diagnoses in 2022, with prostate cancer anticipated to remain the most diagnosed cancer type. Additionally, increasing awareness campaigns related to cancer are anticipated to drive market growth in the region. The cancer awareness month in September in the United States highlights the government's commitment to support patients and their families, improving access to care, and promoting the importance of early detection. These efforts are likely to raise awareness about cancer and contribute to market expansion in North America over the forecast period.

Future Market Scenario (2024 - 2031F)

The rise in cancer patients presents the biggest opportunity for the growing oncology information system market. Advanced and effective approaches have been devised to ensure faster recovery and better results for keeping health in check for cancer patients. R&D and heavy investments made by healthcare giants are promoting developments in the oncology information system market, and this is a huge advantage for this market to flourish in the coming years. New companies in this area are introducing themselves with cutting-edge technologies. In May 2022, Berry Oncology, a firm specializing in genetic testing and early tumor screening, introduced a HIFI system comprising HIFI-det liquid biopsy technology and the corresponding HIFI-cal algorithm series. Successful attempts made towards the betterment of technology also pushes people to further engage with a higher quality of self-care and this paves a way for the market to rise.

Key Players Landscape and Outlook

Several companies, such as Siemens Healthineers, F. Hoffmann-La Roche AG, McKesson Corporation, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Elekta AB, IBM Corporation, Oracle Cerner, Epic Systems Corporation, and RaySearch Laboratories AB, are focusing on market expansion and product launch and development. Oncology information system market participants are poised to encounter promising growth prospects in the global market, driven by the increasing demand for healthcare IT solutions. The primary focus of these leading players is directed towards the rapidly expanding market segment, aiming to thrive and excel in an intensely competitive market environment. Additionally, these market players emphasize collaboration and license agreements as strategic initiatives anticipated to propel market growth.

In May 2022, GE Healthcare partnered with RaySearch Laboratories AB, a provider of radiation oncology software, to develop an innovative radiation therapy simulation and treatment planning workflow solution. This collaboration aims to streamline the radiation targeting process to reduce tumor size.

In September 2022, the International Agency for Research on Cancer announced initiating a new research initiative financed by the European Union (EU). The project's primary objective is to enhance the region's cancer screening data collection systems.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Oncology Information System Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
  • 4.2.By Product and Service
    • 4.2.1.Patient Information Systems
    • 4.2.2.Treatment Planning Systems
    • 4.2.3.Treatment Management & Medical Image Analysis Systems
    • 4.2.4.Consulting & Optimization Services
    • 4.2.5.Implementation Services
    • 4.2.6.Post-sale & Maintenance Services
  • 4.3.By Application
    • 4.3.1.Medical Oncology
    • 4.3.2.Radiation Oncology
    • 4.3.3.Surgical Oncology
  • 4.4.By End-user
    • 4.4.1.Hospitals
    • 4.4.2.Cancer Care Centres
    • 4.4.3.Government Institutes
    • 4.4.4.Research Facilities
    • 4.4.5.Others
  • 4.5.By Region
    • 4.5.1.North America
    • 4.5.2.Europe
    • 4.5.3.Asia-Pacific
    • 4.5.4.South End-user America
    • 4.5.5.Middle East and Africa
  • 4.6.By Company Market Share (%), 2023

5.Global Oncology Information System Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
    • 5.1.2.By Product and Service
      • 5.1.2.1.Patient Information Systems
      • 5.1.2.2.Treatment Planning Systems
      • 5.1.2.3.Treatment Management & Medical Image Analysis Systems
      • 5.1.2.4.Consulting & Optimization Services
      • 5.1.2.5.Implementation Services
      • 5.1.2.6.Post-sale & Maintenance Services
    • 5.1.3.By Application
      • 5.1.3.1.Medical Oncology
      • 5.1.3.2.Radiation Oncology
      • 5.1.3.3.Surgical Oncology
    • 5.1.4.By End-user
      • 5.1.4.1.Hospitals
      • 5.1.4.2.Cancer Care Centres
      • 5.1.4.3.Government Institutes
      • 5.1.4.4.Research Facilities
      • 5.1.4.5.Others
    • 5.1.5.United States*
      • 5.1.5.1.Market Size & Forecast
      • 5.1.5.1.1.By Value
      • 5.1.5.2.By Product and Service
      • 5.1.5.2.1.Patient Information Systems
      • 5.1.5.2.2.Treatment Planning Systems
      • 5.1.5.2.3.Treatment Management & Medical Image Analysis Systems
      • 5.1.5.2.4.Consulting & Optimization Services
      • 5.1.5.2.5.Implementation Services
      • 5.1.5.2.6.Post-sale & Maintenance Services
      • 5.1.5.3.By Application
      • 5.1.5.3.1.Medical Oncology
      • 5.1.5.3.2.Radiation Oncology
      • 5.1.5.3.3.Surgical Oncology
      • 5.1.5.4.By End-user
      • 5.1.5.4.1.Hospitals
      • 5.1.5.4.2.Cancer Care Centres
      • 5.1.5.4.3.Government Institutes
      • 5.1.5.4.4.Research Facilities
      • 5.1.5.4.5.Others
    • 5.1.6.Canada
    • 5.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product and Service
  • 6.2.By Application
  • 6.3.By End-user
  • 6.4.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Case Studies

12.Key Players Outlook

  • 12.1.Siemens Healthineers
    • 12.1.1.Company Details
    • 12.1.2.Key Management Personnel
    • 12.1.3.Products & Services
    • 12.1.4.Financials (As reported)
    • 12.1.5.Key Market Focus & Geographical Presence
    • 12.1.6.Recent Developments
  • 12.2.F. Hoffmann-La Roche AG
  • 12.3.McKesson Corporation
  • 12.4.Koninklijke Philips N.V.
  • 12.5.GE HealthCare Technologies, Inc.
  • 12.6.Elekta Medical Systems India Pvt. Ltd.
  • 12.7.IBM Watson Health
  • 12.8.Oracle Cerner
  • 12.9.Epic Systems Corporation
  • 12.10.RaySearch Laboratories AB

13.Strategic Recommendations

14.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 3.Global Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 4.Global Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 5.Global Oncology Information System Market Share (%), By Region, 2017-2031F
  • Figure 6.North America Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 7.North America Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 8.North America Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 9.North America Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 10.North America Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 11.United States Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 12.United States Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 13.United States Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 14.United States Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 15.Canada Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.Canada Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 17.Canada Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 18.Canada Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 19.Mexico Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 20.Mexico Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 21.Mexico Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 22.Mexico Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 23.Europe Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 24.Europe Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 25.Europe Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 26.Europe Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 27.Europe Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 28.Germany Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 29.Germany Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 30.Germany Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 31.Germany Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 32.France Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 33.France Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 34.France Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 35.France Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 36.Italy Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 37.Italy Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 38.Italy Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 39.Italy Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 40.United Kingdom Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.United Kingdom Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 42.United Kingdom Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 43.United Kingdom Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 44.Russia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 45.Russia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 46.Russia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 47.Russia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 48.Netherlands Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 49.Netherlands Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 50.Netherlands Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 51.Netherlands Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 52.Spain Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Spain Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 54.Spain Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 55.Spain Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 56.Turkey Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 57.Turkey Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 58.Turkey Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 59.Turkey Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 60.Poland Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 61.Poland Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 62.Poland Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 63.Poland Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 64.South America Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.South America Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 66.South America Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 67.South America Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 68.South America Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 69.Brazil Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 70.Brazil Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 71.Brazil Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 72.Brazil Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 73.Argentina Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 74.Argentina Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 75.Argentina Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 76.Argentina Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 77.Asia-Pacific Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 78.Asia-Pacific Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 79.Asia-Pacific Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 80.Asia-Pacific Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 81.Asia-Pacific Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 82.India Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.India Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 84.India Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 85.India Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 86.China Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 87.China Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 88.China Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 89.China Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 90.Japan Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 91.Japan Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 92.Japan Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 93.Japan Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 94.Australia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.Australia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 96.Australia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 97.Australia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 98.Vietnam Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 99.Vietnam Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 100.Vietnam Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 101.Vietnam Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 102.South Korea Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 103.South Korea Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 104.South Korea Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 105.South Korea Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 106.Indonesia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 107.Indonesia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 108.Indonesia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 109.Indonesia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 110.Philippines Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 111.Philippines Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 112.Philippines Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 113.Philippines Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 114.Middle East & Africa Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 115.Middle East & Africa Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 116.Middle East & Africa Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 117.Middle East & Africa Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 118.Middle East & Africa Oncology Information System Market Share (%), By Country, 2017-2031F
  • Figure 119.Saudi Arabia Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 120.Saudi Arabia Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 121.Saudi Arabia Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 122.Saudi Arabia Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 123.UAE Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 124.UAE Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 125.UAE Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 126.UAE Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 127.South Africa Oncology Information System Market, By Value, In USD Billion, 2017-2031F
  • Figure 128.South Africa Oncology Information System Market Share (%), By Product and Service, 2017-2031F
  • Figure 129.South Africa Oncology Information System Market Share (%), By Application, 2017-2031F
  • Figure 130.South Africa Oncology Information System Market Share (%), By End-user, 2017-2031F
  • Figure 131.By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 134.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023